Markets

Market Nav

NINE MONTHS RESULTS

Welcure Drugs & Pharmaceuticals Ltd.
( in Crs.)

ParticularsDec 25Dec 24Dec 23Dec 22Dec 21
Net Sales/Income from operations365.5433.390.000.000.00
Total Income From Operations365.5433.390.000.000.00
Purchase of Traded Goods322.37164.030.000.000.00
Increase/Decrease in Stocks0.00-136.140.000.000.00
Employees Cost0.080.260.080.010.01
Depreciation0.010.010.020.000.00
Other Expenses0.172.820.100.020.06
Total Expenses322.6330.980.190.020.07
      
P/L Before Other Inc. , Int., Excpt. Items & Tax42.912.41-0.19-0.02-0.07
Other Income1.460.000.030.020.02
P/L Before Interest, Excpt. Items & Tax44.372.41-0.16-0.01-0.04
P/L Before Exceptional Items & Tax44.372.41-0.16-0.01-0.04
P/L Before Tax44.372.41-0.16-0.01-0.04
Tax0.970.500.000.000.00
P/L After Tax from Ordinary Activities43.401.91-0.16-0.01-0.04
Net Profit/Loss For the Period43.401.91-0.16-0.01-0.04
      
Equity Share Capital123.59112.4413.4413.4412.12
EPS Before Extra Ordinary *     
Basic EPS (Rs.)0.360.16-0.01-0.01-0.04
Diluted EPS (Rs.)0.360.02-0.01(.00)-0.04
EPS After Extra Ordinary *     
Basic EPS (Rs.) 0.360.16-0.01-0.01-0.04
Diluted EPS (Rs.) 0.360.00-0.010.00-0.04
      
PBITOE Margin (%)11.737.20N.AN.AN.A
PBTE Margin (%)12.137.20N.AN.AN.A
PBT Margin (%)12.137.20N.AN.AN.A
PAT Margin (%)11.875.71N.AN.AN.A
ParticularsDec 25
Net Sales/Income from operations365.54
Total Income From Operations365.54
Purchase of Traded Goods322.37
Increase/Decrease in Stocks0.00
Employees Cost0.08
Depreciation0.01
Other Expenses0.17
Total Expenses322.63
  
P/L Before Other Inc. , Int., Excpt. Items & Tax42.91
Other Income1.46
P/L Before Interest, Excpt. Items & Tax44.37
P/L Before Exceptional Items & Tax44.37
P/L Before Tax44.37
Tax0.97
P/L After Tax from Ordinary Activities43.40
Net Profit/Loss For the Period43.40
Equity Share Capital123.59
EPS Before Extra Ordinary * 
Basic EPS (Rs.)0.36
Diluted EPS (Rs.)0.36
EPS After Extra Ordinary * 
Basic EPS (Rs.) 0.36
Diluted EPS (Rs.) 0.36
PBITOE Margin (%)11.73
PBTE Margin (%)12.13
PBT Margin (%)12.13
PAT Margin (%)11.87